IL10 and graft versus host disease: Overall, these results demonstrate that NGO‐Mac regulates T‐cell proliferation and differentiation via IL‐10–dependent mechanisms, thereby supporting its potential as a macrophage‐based immunoregulatory cell therapy for GVHD.